Key Highlights
- Third quarter net sales rose 110% year over year to USD 38.14 million, ahead of the USD 36.60 million estimate.
- Non-GAAP loss per share was USD 0.05 against an estimated USD 0.16 loss, and non-GAAP gross Margin was 48.7%.
- Cash was USD 363.5 million, no debt, with fourth quarter net sales guided to USD 43.5 to 44.5 million.
- Full-year net sales are guided to about USD 140 million, up from an initial guide above USD 100 million.
Ambiq Micro (NYSE:AMBQ), a maker of ultra-low power semiconductors, reported third quarter 2026 net sales of USD 38.14 million, up 110% from a year earlier and above the USD 36.60 million estimate. Non-GAAP loss per share was USD 0.05, narrower than the USD 0.16 estimated loss. It was the company's sixth consecutive quarter of sequential growth.
Non-GAAP gross margin was 48.7%, up 390 basis points year over year. Non-GAAP net loss was USD 1.2 million, a USD 2.8 million improvement, based on 24.3 million average shares.
Customers and Products
Seven customers generated more than USD 1 million each in net sales during the quarter, up from three a year earlier, and the active customer base grew about 50% year over year. The company said its Apollo330 Plus and Apollo510 Lite platforms are gaining traction across wearables, smart glasses, hearing assist, medical monitoring, smart pens and industrial remote monitoring. It launched or significantly enhanced seven artificial intelligence software products this year.
Looking ahead, management said its Apollo340 platform is intended to broaden Diversification across medical, industrial and smart building markets, and that first customer devices based on newer platforms are scheduled to reach the market in early 2027. It guided to doubling Revenue outside wearables this year.
Guidance and Balance Sheet
For the fourth quarter, management guided net sales to a range of USD 43.5 million to USD 44.5 million, which would be a seventh consecutive quarter of growth. Non-GAAP gross margin is guided to be roughly flat with the third quarter, and non-GAAP Operating Expense to USD 25.5 million to USD 26.5 million, including USD 0.5 million of intellectual property spending and costs tied to two upcoming chip tape-outs. Full-year net sales are now guided to approximately USD 140 million, nearly double 2025 and above an initial expectation of more than USD 100 million.
Cash and cash equivalents were USD 363.5 million at September 30, against USD 140.3 million at year end, and the company reports no debt. The Balance Sheet reflects two follow-on offerings in 2026. In January the company completed an offering of 2,679,600 shares at USD 31.00 per share, with net proceeds of USD 75.3 million to the company, and in June an offering of 2,300,000 shares at USD 78.00, with net proceeds of USD 167.9 million.
Accounts receivable rose to USD 19.0 million from USD 7.3 million, and inventories to USD 30.1 million from USD 16.9 million.
Items to Follow
Delivery against the fourth quarter range, gross margin as Supply chain costs shift, operating expense growth tied to new chip development and the timing of first devices from newer platforms are the measurable items for coming quarters.
_11_19_2026_19_19_13_574021.jpg)





Please wait processing your request...